AYTU BIOPHARMA, INC. (AYTU) Operating margin 2017–2026
AYTU BIOPHARMA, INC. (AYTU) operating margin by fiscal year — reported operating income divided by reported revenue.
-14.4%FY2026 · since FY2017: -624.7% → -14.4%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | -14.4% | -2.7 pp |
| FY2025 | -11.8% | -9.4 pp |
| FY2024 | -2.4% | +13.4 pp |
| FY2023 | -15.9% | +97.8 pp |
| FY2022 | -113.7% | -24.0 pp |
| FY2021 | -89.7% | -13.2 pp |
| FY2020 | -76.5% | +153.7 pp |
| FY2019 | -230.1% | +308.1 pp |
| FY2018 | -538.2% | +86.5 pp |
| FY2017 | -624.7% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More AYTU financial trends
AYTU RevenueAYTU Net incomeAYTU Net marginAYTU Gross profitAYTU Gross marginAYTU Operating incomeAYTU Operating cash flowAYTU Free cash flowAYTU Capital expendituresAYTU Return on equityAYTU Stock buybacksAYTU Dividends paidAYTU Total assetsAYTU Total liabilitiesAYTU Shareholders’ equityAYTU overview →